Bristol-Myers, Allied Minds partner to ID drug candidates, fund startups
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb found a group of like-minded investors in the new company builder Allied Minds, which will help the pharmaceutical giant pull innovative therapeutic research out of academia and finance preclinical proof-of-concept through a joint venture call Allied-Bristol Life Sciences.